Comment on

• The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism.

  Remde H, Dietz A, Emeny R, Riester A, Peters A, de Las Heras Gala T, Then C, Seissler J, Beuschlein F, Reincke M, Quinkler M. Remde H, et al. J Hypertens. 2016 Oct;34(10):2066-73. doi: 10.1097/HJH.0000000000001041. J Hypertens. 2016. PMID: 27442789
• High-sensitive C-reactive protein in primary aldosteronism.

  Tanemoto M. Tanemoto M. J Hypertens. 2017 Jan;35(1):200-201. doi: 10.1097/HJH.0000000000001163. J Hypertens. 2017. PMID: 27902632 No abstract available.